Latest Updates
-
Coconut Rice Recipe: Your South Indian Comfort Meal Awaits -
Sonu Nigam Is In Pain But Won't Leave The Stage — Here's What Pinched Nerves Does To Singers -
Dry Fruit Laddu Recipe: Your Go-To Healthy Sweet Snack -
Father's Day 2026: Indian Celebrity Dads Who Are Rewriting the Rules of Fatherhood -
Dhaba Style Spicy Curry Kadai Chicken Recipe -
Feeling Weak After Malaria? Here's Why Recovery Takes Longer Than You Think -
Muharram 2026: Date, History, Significance, and Rituals Explained -
The Scam That Shook 22 Lakh Students: NEET UG 2026's Paper Leak And Telegram Ban Explained -
Maharana Pratap Jayanti 2026: Significance, History And Legacy Of Mewar’s Warrior King -
Your 5 Minute Energy Boost: The Ultimate Chocolate Shake Recipe
Vitamin Therapy May Prevent Deadly Skin Cancer: Study
Read to know how vitamin therapy can be used to prevent skin cancer.
A therapy using a form of Vitamin B3 can potentially prevent melanoma - a deadly skin cancer - according to scientists, including one of Indian origin. Researchers from University of Sydney in Australia found that nicotinamide can help reduce or reverse DNA damage, inflammation, and immunosuppression caused by ultraviolet radiation.

The cost of nicotinatimide is about USD 10 per month if taken at one gramme per day as recommended, researchers said. Randomised placebo controlled trials are now warranted to determine its efficacy and safety for melanoma prevention, they said. Ultraviolet radiation (UVR) causes DNA damage in melanocytes by producing photolesions such as cyclobutane pyrimidine dimers and 8-oxo-7-hydrodeoxyguanosine.
The production of reactive oxygen species by UVR also induces inflammatory cytokines that, together with the inherent immunosuppressive properties of UVR, propagate carcinogenesis, researchers said. Nicotinamide (Vitamin B3) enhances DNA repair, modulates the inflammatory environment produced by UVR, and reduces UV- induced immunosuppression.
As nicotinamide reduces the incidence of actinic keratoses and nonmelanoma skin cancers in high-risk individuals and enhances repair of DNA damage in melanocytes, it is a promising agent for the chemoprevention of melanoma in high-risk populations.

"Nicotinamide has been show in a clinical trial - called ONTRAC - to reduce the incidence of non-melanoma skin cancer in high-risk individuals and it would be worthwhile to determine whether it would also be useful for high-risk melanoma patients," said Gary Halliday from University of Sydney. The study was published in the Photodermatology, Photoimmunology and Photomedicine.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications